Article
Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications.
Journal of thrombosis and haemostasis : JTH - 1 Mar 2021
Chaturvedi Shruti, Braunstein Evan M, Brodsky Robert A
Abstract excerpt
Antiphospholipid syndrome (APS) is an acquired thromboinflammatory disorder characterized by the presence of antiphospholipid antibodies as well as an increased frequency of venous or arterial thrombosis and/or obstetrical morbidity. The spectrum of disease varies from asymptomatic to a severe form characterized by widespread thrombosis and multiorgan failure, termed catastrophic APS (CAPS). CAPS affects only...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
